Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.51−0.02 (-1.31%)
Close on Nov 13, 2026Market cap $850.64KP/E –Yield –
Universe Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Universe Pharmaceuticals's total debt was $7.38M at Mar 31, 2026. For fiscal 2025 it was $9.26M, down 99.8% from the year before. The highest annual figure on record is $5.86B in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $9.26M | -99.8% |
| FY2024 | Sep 30, 2024 | $5.86B | +106726.3% |
| FY2023 | Sep 30, 2023 | $5.48M | +39.3% |
| FY2022 | Sep 30, 2022 | $3.94M | -9.2% |
| FY2021 | Sep 30, 2021 | $4.33M | +63.8% |
| FY2020 | Sep 30, 2020 | $2.65M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $7.38M | +81.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $9.26M | +135.2% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $5.86B | +132705.1% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.48M | +26.5% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $4.08M | +54.1% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $3.94M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $4.41M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $4.33M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $2.65M | – |
See a number that looks wrong?